MR-less surface-based amyloid estimation by subject-specific atlas selection and Bayesian fusion

Med Image Comput Comput Assist Interv. 2012;15(Pt 2):220-7. doi: 10.1007/978-3-642-33418-4_28.

Abstract

For clinical evaluation, assessing amyloid deposition with PiB-PET is desirable without requiring MR acquisition and associated fusion/segmentation techniques. A useful clinical tool is to estimate PiB-PET against the brain surface, which is however challenging using PET alone because of the lack of structural information. We propose a method to generate such estimate, where multiple atlases are selected and combined with local weights in a Bayesian framework. Qualitative and quantitative comparison with and without MRI are presented. Using PET only, the average error on the brain surface was around 13% compared to MRI-dependant method.

MeSH terms

  • Algorithms
  • Alzheimer Disease / diagnostic imaging*
  • Alzheimer Disease / metabolism*
  • Amyloidogenic Proteins / metabolism*
  • Aniline Compounds
  • Bayes Theorem
  • Benzothiazoles*
  • Brain / diagnostic imaging*
  • Brain / metabolism*
  • Female
  • Humans
  • Image Enhancement / methods
  • Image Interpretation, Computer-Assisted / methods
  • Magnetic Resonance Imaging
  • Male
  • Pattern Recognition, Automated / methods
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Subtraction Technique
  • Thiazoles

Substances

  • 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
  • Amyloidogenic Proteins
  • Aniline Compounds
  • Benzothiazoles
  • Radiopharmaceuticals
  • Thiazoles